Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468106![]() (CHEMBL4280801 | US11247985, Table 3.49) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536747![]() (US11247985, Table 3.51) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536749![]() (US11247985, Table 3.53) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50514013![]() (CHEMBL4445673 | US11247985, Table 3.55) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536753![]() (US11247985, Table 3.57) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468108![]() (CHEMBL4280125 | US11247985, Table 3.59) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50158905![]() (CHEMBL3787674 | US11247985, Table 3.61) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468112![]() (CHEMBL4277404 | US11247985, Table 3.63) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536761![]() (US11247985, Table 3.65 | US11247985, Table 3.78) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 47 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468110![]() (CHEMBL4288865 | US11247985, Table 3.67) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536765![]() (US11247985, Table 3.69) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536767![]() (US11247985, Table 3.71) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 86 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536769![]() (US11247985, Table 3.73) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 87 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536771![]() (US11247985, Table 3.75) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536775![]() (US11247985, Table 3.79) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536773![]() (US11247985, Table 3.77) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468118![]() (CHEMBL4280546 | US11247985, Table 3.1) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536777![]() (US11247985, Table 3.81) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536779![]() (US11247985, Table 3.83) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536781![]() (US11247985, Table 3.85) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536783![]() (US11247985, Table 3.87) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468116![]() (CHEMBL4276697 | US11247985, Table 3.91) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536785![]() (US11247985, Table 3.89) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536791![]() (US11247985, Table 3.95) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468123![]() (CHEMBL4291440 | US11247985, Table 3.97) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468105![]() (CHEMBL4288427 | US11247985, Table 3.99) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536789![]() (US11247985, Table 3.93) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536801![]() (US11247985, Table 3.105) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536799![]() (US11247985, Table 3.103) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536797![]() (US11247985, Table 3.101) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536705![]() (US11247985, Table 3.9) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536807![]() (US11247985, Table 3.111) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536809![]() (US11247985, Table 3.113) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536803![]() (US11247985, Table 3.107) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536805![]() (US11247985, Table 3.109) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536811![]() (US11247985, Table 3.115) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536703![]() (US11247985, Table 3.7) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468115![]() (CHEMBL4278176 | US11247985, Table 3.117) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 175 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536815![]() (US11247985, Table 3.119) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468122![]() (CHEMBL4291849 | US11247985, Table 3.15) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536817![]() (US11247985, Table 3.121) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50158906![]() (CHEMBL3785307 | US11247985, Table 3.123) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536701![]() (US11247985, Table 3.5) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536821![]() (US11247985, Table 3.125) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536825![]() (US11247985, Table 3.129) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536823![]() (US11247985, Table 3.127) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536715![]() (US11247985, Table 3.19) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536699![]() (US11247985, Table 3.3) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468121![]() (CHEMBL4293387 | US11247985, Table 3.131) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536829![]() (US11247985, Table 3.133) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 435 total ) | Next | Last >> |